These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 9760024

  • 1. Evaluation of cannabimimetic effects of structural analogs of anandamide in rats.
    Wiley JL, Ryan WJ, Razdan RK, Martin BR.
    Eur J Pharmacol; 1998 Aug 21; 355(2-3):113-8. PubMed ID: 9760024
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
    Di Marzo V, Berrendero F, Bisogno T, González S, Cavaliere P, Romero J, Cebeira M, Ramos JA, Fernández-Ruiz JJ.
    J Neurochem; 2000 Apr 21; 74(4):1627-35. PubMed ID: 10737621
    [Abstract] [Full Text] [Related]

  • 3. Cannabis: discrimination of "internal bliss"?
    Wiley JL.
    Pharmacol Biochem Behav; 1999 Oct 21; 64(2):257-60. PubMed ID: 10515300
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys.
    Wiley JL, Golden KM, Ryan WJ, Balster RL, Razdan RK, Martin BR.
    Pharmacol Biochem Behav; 1997 Dec 21; 58(4):1139-43. PubMed ID: 9408225
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs.
    Adams IB, Ryan W, Singer M, Thomas BF, Compton DR, Razdan RK, Martin BR.
    J Pharmacol Exp Ther; 1995 Jun 21; 273(3):1172-81. PubMed ID: 7791088
    [Abstract] [Full Text] [Related]

  • 6. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
    Lin S, Khanolkar AD, Fan P, Goutopoulos A, Qin C, Papahadjis D, Makriyannis A.
    J Med Chem; 1998 Dec 31; 41(27):5353-61. PubMed ID: 9876105
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological and behavioral evaluation of alkylated anandamide analogs.
    Adams IB, Ryan W, Singer M, Razdan RK, Compton DR, Martin BR.
    Life Sci; 1995 Dec 31; 56(23-24):2041-8. PubMed ID: 7776830
    [Abstract] [Full Text] [Related]

  • 8. Discriminative stimulus effects of anandamide in rats.
    Wiley J, Balster R, Martin B.
    Eur J Pharmacol; 1995 Mar 24; 276(1-2):49-54. PubMed ID: 7781695
    [Abstract] [Full Text] [Related]

  • 9. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.
    Wiley JL, Martin BR.
    Chem Phys Lipids; 2002 Dec 31; 121(1-2):57-63. PubMed ID: 12505690
    [Abstract] [Full Text] [Related]

  • 10. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance.
    Mallet PE, Beninger RJ.
    Life Sci; 1998 Dec 31; 62(26):2431-9. PubMed ID: 9651110
    [Abstract] [Full Text] [Related]

  • 11. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds.
    Sugiura T, Kodaka T, Nakane S, Miyashita T, Kondo S, Suhara Y, Takayama H, Waku K, Seki C, Baba N, Ishima Y.
    J Biol Chem; 1999 Jan 29; 274(5):2794-801. PubMed ID: 9915812
    [Abstract] [Full Text] [Related]

  • 12. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
    Järbe TU, Lamb RJ, Lin S, Makriyannis A.
    Psychopharmacology (Berl); 2001 Aug 29; 156(4):369-80. PubMed ID: 11498713
    [Abstract] [Full Text] [Related]

  • 13. Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats.
    Rubino T, Viganò D, Costa B, Colleoni M, Parolaro D.
    J Neurochem; 2000 Dec 29; 75(6):2478-84. PubMed ID: 11080200
    [Abstract] [Full Text] [Related]

  • 14. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].
    Shivachar AC, Martin BR, Ellis EF.
    Biochem Pharmacol; 1996 Mar 08; 51(5):669-76. PubMed ID: 8615904
    [Abstract] [Full Text] [Related]

  • 15. Functional role of high-affinity anandamide transport, as revealed by selective inhibition.
    Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D.
    Science; 1997 Aug 22; 277(5329):1094-7. PubMed ID: 9262477
    [Abstract] [Full Text] [Related]

  • 16. Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice.
    Wiley JL, Smith FL, Razdan RK, Dewey WL.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):59-68. PubMed ID: 15740725
    [Abstract] [Full Text] [Related]

  • 17. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.
    Pertwee RG, Stevenson LA, Griffin G.
    Br J Pharmacol; 1993 Dec 07; 110(4):1483-90. PubMed ID: 8306090
    [Abstract] [Full Text] [Related]

  • 18. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
    Ameri A, Wilhelm A, Simmet T.
    Br J Pharmacol; 1999 Apr 07; 126(8):1831-9. PubMed ID: 10372827
    [Abstract] [Full Text] [Related]

  • 19. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture.
    Kim D, Thayer SA.
    J Neurosci; 2001 May 15; 21(10):RC146. PubMed ID: 11319244
    [Abstract] [Full Text] [Related]

  • 20. Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells.
    Lau AH, Chow SS.
    Eur J Pharmacol; 2003 Mar 19; 464(2-3):229-35. PubMed ID: 12620517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.